Quantcast

Latest squamous cell carcinoma Stories

2011-03-16 08:20:01

(Ivanhoe Newswire) -- Heavy drinking is not associated with one of the two most common types of gullet (oesophageal) cancer, according to this study. Gullet cancer is the sixth leading cause of cancer death worldwide and occurs as one of two main types: squamous cell carcinoma or adenocarcinoma. But while rates of gullet adenocarcinoma have soared in many Western countries over the past three decades, those of squamous cell carcinoma have been falling. The squamous cell variety is strongly...

2011-03-15 14:34:19

Alcohol intake and risk of esophageal adenocarcinoma: A pooled analysis from the BEACON Consortium Heavy drinking is not associated with one of the two most common types of gullet (oesophageal) cancer, suggests research published online in Gut. Gullet cancer is the sixth leading cause of cancer death worldwide and occurs as one of two main types: squamous cell carcinoma or adenocarcinoma. But while rates of gullet adenocarcinoma have soared in many Western countries over the past three...

2011-03-08 07:41:28

(Ivanhoe Newswire) "“ When do organs know to stop growing? The answer could be useful in regenerative medicine, and also in cancer- where there "stop growing" signals either aren't issued or aren't listened to. Researchers have found a regulator of gene activity that tells epidermal stem cells when it's time to grow more skin, as well as a "crowd control" molecule that senses stem cell crowding and turns the growth off. The work, in mice and in human cancer cells, provides clues to new...

2011-03-03 11:00:00

Molecular "switch" turns stem cells on or off; could help burn victims and patients with squamous cell carcinoma BOSTON, March 3, 2011 /PRNewswire-USNewswire/ -- How do organs "know" when to stop growing? The answer could be useful in regenerative medicine, and also in cancer - where these "stop growing" signals either aren't issued or aren't heeded. Researchers in the Stem Cell Program at Children's Hospital Boston have now found a regulator of gene activity that tells epidermal stem...

2011-03-02 16:46:43

Melatonin is known to have cancer-protective properties, and shift work can induce desynchrony of the circadian system, reducing melatonin production. Shift work has been thought to have important health impacts, with evidence linking shift work to an increased risk of several cancers including breast, endometrial, prostate, and colorectal, and non-Hodgkin lymphoma.  In a recent study, researchers at Brigham and Women's Hospital (BWH) found that shift work may be associated with a...

2011-02-27 00:01:40

Tans are caused by harmful ultraviolet (UV) radiation from the sun or tanning lamps, and if you've had one, you've sustained skin cell damage. Middleburg, VA (PRWEB) February 25, 2011 With Spring Break approaching, The Less Cancer Campaign wishes to remind sun worshippers of some of the dangers of tanning. The Skin Cancer Foundation tells us that a tan, whether you get it on the beach, in a bed, or through incidental exposure, is bad news any way you acquire it. Tans are caused by harmful...

2011-02-25 13:11:30

Phase III results At the 3rd International Conference on innovative approaches in Head and Neck Oncology (ICHNO), Dr Hanna Rahbek Mortensen and colleagues at hospitals and institutes in Denmark presented results from a large prospective trial, the DAHANCA 6 & 7 study. The study, conducted across the country, investigated risk factors for developing dysphagia (swallowing dysfunction), after undergoing radiotherapy treatment for a head & neck cancer. "We followed 1,476 patients with...

2011-02-24 21:11:23

Validation of a gene expression signature for distinguishing metastasizing from non-metastasizing tumors in head and neck cancers, on a large multi-center cohort The validation of a test, based on gene expression and predicting the tumours that will metastasize in lymph nodes of head & neck cancers, was presented today at the 3rd International Conference on innovative approaches in Head and Neck Oncology (ICHNO), in Barcelona. Dr Robert Takes, from the Radboud University Nijmegen Medical...

2011-02-23 00:30:00

SEATTLE, Feb. 23, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that updated phase II study results of OPAXIO (paclitaxel poliglumex) in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the February 3, 2011 issue of the American Journal of Clinical Oncology, Dipetrillo, et al., which demonstrate that 38% (15/40) of the patients receiving OPAXIO in combination with cisplatin and...

2011-02-22 02:50:48

Sharing printed educational materials about the risk of squamous cell carcinoma with kidney transplant recipients appeared to be effective at increasing skin self-examination and encouraging follow-up with a dermatologist to determine risk of cancer, according to a report posted online today that will appear in the June issue of Archives of Dermatology, one of the JAMA/Archives journals. "In the United States, an estimated 100,000 living kidney transplant recipients are at risk to develop...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related